NETHERLANDS – The world’s leading bioscience company, DuPont has unveiled plans for new European headquarters for Industrial Biosciences in the Netherlands to expand its research and innovation capabilities.
The elaborate facility is located at its new site in Leiden Bio Science Park, Oegstgeest, the Netherlands.
The facility will create additional 100 jobs, doubling the growth potential of its current employee base.
It will host experts in various fields including research and development, application development, marketing, sales and customer service, with a focused goal to develop sustainable enzyme solutions that improve product performance.
The building will serve as the new EMEA (Europe, Middle East and Africa) headquarters for DuPont Industrial Biosciences.
“Our Leiden scientists have been developing innovations that enable our customers to improve the efficiency and sustainability of their processes and products for many years,” said Simon Herriott, Vice President & Global Business Director for Bioactives at DuPont.
“This new facility will enable our teams to do even more – to improve the pace of biotechnology and the speed with which we can deliver it to market.
The ecosystem of talent, academia and community we find in the Leiden Bio Science Park is ideal for our work and for keeping us globally competitive.”
According to the company, the new DuPont Industrial Biosciences base features cutting-edge biotechnology laboratories equipped with tools of modern biotechnology.
It provides a platform where DuPont can efficiently and more sustainably develop and market enzymes and other bioactives, biomaterials and industry-related materials.
The building, set to be completed in 2020, will be constructed by Dura Vermeer and will cover 7250 square meters, doubling of the capacity of the current facility for the business.
The company said the project will receive a BREEAM “Excellent” rating, an impressive measure of a building’s sustainability and environmental footprint.
To further expand its biotechnology capabilities, DuPont Industrial Biosciences acquired enzyme and technology assets from Dyadic International in 2015.
It unveiled plans to open a new innovation site in Japan last year to serve bakery, beverage and dairy industries.
Also, the company in August said it was expanding its R&D team by creating a ‘clean label hub’ at the Brabrand facility.